Showing 1 - 10 of 1,751
Using recent data on the unvaccinated across U.S. states, this paper focuses on the determinants of vaccine hesitancy related to the COVID-19 pandemic. Results show that more prosperous states and states with more elderly and physicians have lower vaccine hesitancy. There was some evidence of...
Persistent link: https://www.econbiz.de/10013168039
In this paper we empirically analyze the effect of the vaccinations against the SARS-CoV-2 virus on the Covid-19 pandemic for European countries from February 2021 to February 2022 with weekly data. We perform panel fixed effects estimations, GMM estimations and nonlinear penalized spline...
Persistent link: https://www.econbiz.de/10012939110
Persistent link: https://www.econbiz.de/10012873116
We investigate how politico-economic factors shaped government responses to the spread of COVID-19. Our simple framework uses epidemiological, economic and politico-economic arguments. Confronting the theory with US state level data we find strong evidence for partisanship even when we control...
Persistent link: https://www.econbiz.de/10012801483
The emergence of Covid-19 has affected all aspects of human life across the globe. Lockdowns everywhere are having dramatic social and economic consequences. No therapy has yet been approved, and vaccines are a priority potential tool to control the pandemic and its impacts. Multiple vaccines...
Persistent link: https://www.econbiz.de/10012692233
Persistent link: https://www.econbiz.de/10012514154
Persistent link: https://www.econbiz.de/10012514184
Persistent link: https://www.econbiz.de/10012517094
In this study, we use random assignment of vignettes that feature optimistic and pessimistic scenarios with respect to vaccine safety and efficacy on a sample of roughly 1,600 Russians in order to gauge public support for anti-pandemic measures under various scenarios. Negative information on...
Persistent link: https://www.econbiz.de/10012589316
The coronavirus disease (COVID-19) outbreak has resulted in the death of over four million people since late 2019. To reduce the human and economic costs of COVID-19, different vac-cines have been developed and distributed across countries. There has been significant cross-country variation in...
Persistent link: https://www.econbiz.de/10012622723